Home NDC 65862-031 Mirtazapine
Product NDC 65862-031
11-digit product format 658620031
Labeler code 65862
Product ID 65862-031_e26778b1-5226-4107-9d12-3e8b7038bccc
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Mirtazapine
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Aurobindo Pharma Limited
Application ANDA076921
Marketing category ANDA
Marketing start 2004-10-22
Substance MIRTAZAPINE
Active strength 15 mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes NDC auxiliary status# These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
Current NDC status page 1 of 1 · 2 matching rows.
Dataset, Scope, Product NDC table Dataset Scope Product NDC Package NDC Code Status Reporting period Source date unfinished product product 65862-031 UNFINISHED Active or certified unfinished drug listing 2026-10-12 unfinished package package 65862-031 65862-031-19 UNFINISHED Active or certified unfinished drug listing 2026-10-12
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 42 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 65862-031-19 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 unfinished product product 1d862106b807…00c93037cd84…2025-08-26 23:59 UTC · source 2025-08-26 unfinished package package 65862-031-19 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 unfinished product product 390b4c401c3f…2c692c2daee3…2025-05-15 14:59 UTC · source 2025-05-14 unfinished package package 65862-031-19 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 unfinished product product e30019b0c005…a3f0b14938b7…2025-04-01 07:37 UTC · source 2025-03-31 unfinished package package 65862-031-19 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 unfinished product product bbbc9f937eca…946b9c97cf81…2025-03-01 13:19 UTC · source 2025-02-28 unfinished package package 65862-031-19 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 unfinished product product f268b84574a6…26285f5ac5df…2025-02-27 05:24 UTC · source 2025-02-26 unfinished package package 65862-031-19 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 unfinished product product f764e8902f78…92046438deef…2025-02-01 13:13 UTC · source 2025-01-31 unfinished package package 65862-031-19 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 unfinished product product 68b1e3bced9e…98a755eb8bc6…2025-01-20 13:05 UTC · source 2025-01-17 unfinished package package 65862-031-19 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 unfinished product product 05c55d027831…ca05dca9dc4c…2024-11-29 20:42 UTC · source 2024-11-29 unfinished package package 65862-031-19 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 unfinished product product 48b4f40e6753…c7c7a00d2afa…2024-11-09 02:36 UTC · source 2024-11-08 unfinished package package 65862-031-19 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 unfinished product product 27f29a85d7e4…1372111e901f…2024-10-09 02:27 UTC · source 2024-10-08 unfinished package package 65862-031-19 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 unfinished product product 8d62ce987f31…9fe9ef23e30d…2024-07-10 04:00 UTC · source 2024-07-09 unfinished package package 65862-031-19 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished product product d1e113ab4d42…063ee3eb0a1d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished package package 65862-031-19 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 unfinished product product 50b4072663b7…eae3003ed65e…2024-05-15 03:51 UTC · source 2024-05-14 unfinished package package 65862-031-19 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 unfinished product product 906f6e251498…bf70b80e44f0…2022-04-09 23:13 UTC · source 2022-04-08 unfinished package package 65862-031-19 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 unfinished product product 6db9cb8d1e19…3449e1ec5b70…2021-12-27 23:28 UTC · source 2021-12-27 unfinished package package 65862-031-19 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 unfinished product product 8fc7167e32ce…e96bbc724034…2021-02-18 23:40 UTC · source 2021-02-18 unfinished package package 65862-031-19 8fc7167e32ce…e96bbc724034…2020-12-18 03:04 UTC · source 2020-12-17 unfinished product product 4184dd79f89f…545327b3e20f…2020-12-18 03:04 UTC · source 2020-12-17 unfinished package package 65862-031-19 4184dd79f89f…545327b3e20f…2020-06-10 20:45 UTC · source 2020-06-10 unfinished product product 4bd3596a7b87…5c64c6f6865f…2020-06-10 20:45 UTC · source 2020-06-10 unfinished package package 65862-031-19 4bd3596a7b87…5c64c6f6865f…2019-12-08 06:16 UTC · source 2019-12-05 unfinished product product 263afe128892…91768de4ddbe…2019-12-08 06:16 UTC · source 2019-12-05 unfinished package package 65862-031-19 263afe128892…91768de4ddbe…2019-06-01 22:24 UTC · source 2019-05-30 unfinished product product 5b2001dcd8f5…54b53d4dc9e4…2019-06-01 22:24 UTC · source 2019-05-30 unfinished package package 65862-031-19 5b2001dcd8f5…54b53d4dc9e4…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076921-001 MIRTAZAPINE MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 A076921-002 MIRTAZAPINE MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 A076921-003 MIRTAZAPINE MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 A076921-004 MIRTAZAPINE MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076921-001 MIRTAZAPINE 7.5MG TABLET / ORAL AB 2004-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076921-002 MIRTAZAPINE 15MG TABLET / ORAL AB 2004-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076921-003 MIRTAZAPINE 30MG TABLET / ORAL AB 2004-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076921-004 MIRTAZAPINE 45MG TABLET / ORAL AB 2004-10-22 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 172 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Mirtazapine
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MIRTAZAPINE 15 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination A051Q2099Q Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 311725 Internal RxNorm lookup 311726 Internal RxNorm lookup 314111 Internal RxNorm lookup 476809 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65862-031-01 Mirtazapine 100 in 1 BOTTLE TABLET, FILM COATED 100 19 65862-031-05 Mirtazapine 500 in 1 BOTTLE TABLET, FILM COATED 500 19 65862-031-30 Mirtazapine 30 in 1 BOTTLE TABLET, FILM COATED 30 19 65862-031-32 Mirtazapine 30 in 1 BLISTER PACK TABLET, FILM COATED 30 19 65862-031-60 Mirtazapine 60 in 1 BOTTLE TABLET, FILM COATED 60 19 65862-031-90 Mirtazapine 90 in 1 BOTTLE TABLET, FILM COATED 90 19
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MIRTAZAPINE ACTIVE INGREDIENT A051Q2099Q MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 MIRTAZAPINE ACTIVE MOIETY A051Q2099Q MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED INACTIVE INGREDIENT 2165RE0K14 MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 9 MIRTAZAPINE ACTIVE INGREDIENT A051Q2099Q MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 MIRTAZAPINE ACTIVE MOIETY A051Q2099Q MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 HYDROXYPROPYL CELLULOSE INACTIVE INGREDIENT RFW2ET671P MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED INACTIVE INGREDIENT 2165RE0K14 MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MIRTAZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65862-031 MIRTAZAPINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 18 Current NDC, Legacy NDC, 6 package rows 20240126_a4c012f0-50b6-42fb-9f06-a14632f23f2e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 3 of 3 · 44 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Mirtazapine MIRTAZAPINE Proficient Rx LP a96e0d95-1a7b-4588-923a-2169b5506203 2021-01-01 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 076921 application number: ANDA076921 Mirtazapine MIRTAZAPINE NCS HealthCare of KY, Inc dba Vangard Labs 20a724c6-feba-40e7-a35a-8a37de2e0136 2019-03-08 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 076921 application number: ANDA076921 Mirtazapine MIRTAZAPINE Aphena Pharma Solutions - Tennessee, LLC 3bda4994-cdf5-47b4-aebc-7297347334e9 2018-08-24 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 076921 application number: ANDA076921 Mirtazapine MIRTAZAPINE Aphena Pharma Solutions - Tennessee, LLC 6ad0e695-92ee-4900-b194-a2455473370b 2018-07-31 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 076921 application number: ANDA076921
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 65862-031-01 65862003101 100 TABLET, FILM COATED in 1 BOTTLE (65862-031-01) 2004-10-22 0000-00-00 No No Current 65862-031-05 65862003105 500 TABLET, FILM COATED in 1 BOTTLE (65862-031-05) 2004-10-22 0000-00-00 No No Current 65862-031-19 65862003119 10000 TABLET, FILM COATED in 1 BAG (65862-031-19) 22-OCT-04 Current 65862-031-30 65862003130 30 TABLET, FILM COATED in 1 BOTTLE (65862-031-30) 2004-10-22 0000-00-00 No No Current 65862-031-32 65862003132 30 TABLET, FILM COATED in 1 BLISTER PACK (65862-031-32) 2004-10-22 0000-00-00 No No Current 65862-031-60 65862003160 60 TABLET, FILM COATED in 1 BOTTLE (65862-031-60) 2004-10-22 0000-00-00 No No Current 65862-031-90 65862003190 90 TABLET, FILM COATED in 1 BOTTLE (65862-031-90) 2004-10-22 0000-00-00 No No Current